Chain Drug Review - Able approval

Able Laboratories Inc. has received FDA approval of its abbreviated new drug application for Indomethacin Extended Relief capsules, a generic version of Eon Labs’ Indocin SR capsules, which are used to treat rheumatoid arthritis and other conditions.

Related Results

Trust, E-innovation and Leadership in ChangeForeign Banks in United States Since World War II: A Useful FringeBuilding Your Brand With Brand Line ExtensionsThe Impact of the Structure of Debt on Target GainsProject Management Standard Program

COPYRIGHT 2002 Racher Press, Inc.
COPYRIGHT 2008 Gale, Cengage Learning